.

.


LogOff Samples
The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. Sitafloxacin: in bacterial infections.
    Drugs (Drugs ) Vol: 71 Issue 6 Pages: 731-44
    Pub: 2011 Apr 16 Epub:
    • Keating GM

  2. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Mikrobiyoloji bulteni (Mikrobiyol Bul ) Vol: 48 Issue 4 Pages: 523-37
    Pub: 2014 Oct Epub:
    • Atmaca O
    • Zarakolu P
    • Karahan C
    • Cakir B
    • Unal S

  3. Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 51 Issue 3 Pages: 625-30
    Pub: 2003 Mar Epub:
    • El Kholy A
    • Baseem H
    • Hall GS
    • Procop GW
    • Longworth DL

  4. Bacteriologic profile and antibiogram of blood culture isolates from a children`s hospital in Kabul.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP (J Coll Physicians Surg Pak ) Vol: 24 Issue 6 Pages: 396-399
    Pub: 2014 Jun Epub:
    • Tariq TM

  5. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 8 Suppl B Issue Pages: 187-211
    Pub: 1981 Sep Epub:
    • Jones RN
    • Barry AL
    • Thornsberry C
    • Gerlach EH
    • Fuchs PC
    • Gavan TL
    • Sommers HM

  6. A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin.
    Microbiology (Reading, England) (Microbiology ) Vol: 156 Issue Pt 11 Pages: 3354-9
    Pub: 2010 Nov Epub: 2010 Aug 19
    • Tannock GW
    • Munro K
    • Taylor C
    • Lawley B
    • Young W
    • Byrne B
    • Emery J
    • Louie T

  7. Metronidazole. A therapeutic review and update.
    Drugs (Drugs ) Vol: 54 Issue 5 Pages: 679-708
    Pub: 1997 Nov Epub:
    • Freeman CD
    • Klutman NE
    • Lamp KC

  8. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    International journal of antimicrobial agents (Int J Antimicrob Agents ) Vol: 43 Issue 2 Pages: 170-8
    Pub: 2014 Feb Epub: 2013 Nov 15
    • Kanj SS
    • Whitelaw A
    • Dowzicky MJ

  9. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
    Journal of hepatology (J Hepatol ) Vol: 60 Issue 4 Pages: 824-31
    Pub: 2014 Apr Epub: 2013 Dec 6
    • Vrieze A
    • Out C
    • Fuentes S
    • Jonker L
    • Reuling I
    • Kootte RS
    • van Nood E
    • Holleman F
    • Knaapen M
    • Romijn JA
    • Soeters MR
    • Blaak EE
    • Dallinga-Thie GM
    • Reijnders D
    • Ackermans MT
    • Serlie MJ
    • Knop FK
    • Holst JJ
    • van der Ley C
    • Kema IP
    • Zoetendal EG
    • de Vos WM
    • Hoekstra JB
    • Stroes ES
    • Groen AK
    • Nieuwdorp M

  10. An in vitro study to assess the impact of tetracycline on the human intestinal microbiome.
    Anaerobe (Anaerobe ) Vol: 49 Issue Pages: 85-94
    Pub: 2017 Dec 30 Epub: 2017 Dec 30
    • Jung JY
    • Ahn Y
    • Khare S
    • Gokulan K
    • Piñeiro SA
    • Cerniglia CE

Full list available by paid subscriptions

For More information see this summary.